SYDNEY, AU, Feb 15, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials,…
Surabaya, East Java, Indonesia, Nov 14, 2022 – (ACN Newswire via SEAPRWire.com) – The Food and Drug Supervisory Agency (BPOM) has issued emergency use authorization…
HONG KONG, Oct 5, 2022 – (ACN Newswire via SEAPRWire.com) – AIM Vaccine Co., Ltd. (“AIM Vaccine” or the “Company”, together with its subsidiaries, the…
BANDUNG, INDONESIA, Oct 2, 2022 – (ACN Newswire via SEAPRWire.com) – PT Bio Farma (Persero), the holding company for pharmaceutical state-owned enterprises (SOEs), will export…
HONG KONG, Sep 23, 2022 – (ACN Newswire via SEAPRWire.com) – AIM Vaccine Co., Ltd. (“AIM Vaccine” or the “Company”, together with its subsidiaries, the…
BANDUNG, INDONESIA, Sep 12, 2022 – (ACN Newswire via SEAPRWire.com) – PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a…
Bandung, W Java, Indonesia, Sep 9, 2022 – (ACN Newswire via SEAPRWire.com) – PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia,…
Cambridge, MA, Jul 19, 2022 – (ACN Newswire via SEAPRWire.com) – Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today…
SEOUL, S.KOREA, Jul 13, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services…
HONG KONG, Apr 7, 2022 – (ACN Newswire via SEAPRWire.com) – On 31 March 2022, Legend Capital’s portfolio company Jiangsu Recbio Technology Co., Ltd. (“Recbio”,…
HONG KONG, Apr 1, 2022 – (ACN Newswire via SEAPRWire.com) – On March 31, the China-based novel vaccines company – Jiangsu Recbio Technology Co., Ltd.…
HONG KONG, Mar 21, 2022 – (ACN Newswire via SEAPRWire.com) – The China-based novel vaccines company – Jiangsu Recbio Technology Co., Ltd. (“Recbio” or the…
HONG KONG, Feb 18, 2022 – (ACN Newswire via SEAPRWire.com) – Global pandemic control is still facing enormous challenges after more than two years since…
Cambridge, MA, Feb 17, 2022 – (ACN Newswire via SEAPRWire.com) – Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today…
HANGZHOU, CHINA, Jan 12, 2022 – (ACN Newswire via SEAPRWire.com) – On January 8, AIM Vaccine held a meeting at Shulan (Hangzhou) Hospital to report…